EUVIMEDEUVIMED entdecken
Crossref

Intravitreal Melphalan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma

Fariba Ghassemi, Carol L Shields

Archives of Ophthalmology · 01.10.2012 · 130 (10) · 1268

DOI: 10.1001/archophthalmol.2012.1983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Ophthalmology, erschienen am 01.10.2012. Verfasst von Fariba Ghassemi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran. Hauptthemen laut MEDLINE: Neoplasm Seeding. Die Arbeit wurde bisher 147-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm SeedingAntineoplastic Agents, AlkylatingChildChild, PreschoolFollow-Up StudiesHumansInfantIntravitreal InjectionsMelphalanNeoplasm Recurrence, LocalRadiotherapy, AdjuvantRetinal NeoplasmsRetinoblastomaTreatment OutcomeVitreous Body

Substanzen

Antineoplastic Agents, AlkylatingMelphalan

Autor:innen und Institutionen

  • Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Zitieren

APA

Ghassemi, F., & Shields, C. L. (2012). Intravitreal Melphalan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma. Archives of Ophthalmology, 130(10), 1268. https://doi.org/10.1001/archophthalmol.2012.1983

Vancouver

Ghassemi F, Shields CL. Intravitreal Melphalan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma. Archives of Ophthalmology. 2012;130(10):1268. doi:10.1001/archophthalmol.2012.1983

BibTeX
@article{Ghassemi2012,
  author = {Ghassemi, Fariba and Shields, Carol L},
  title = {Intravitreal Melphalan for Refractory or Recurrent Vitreous Seeding From Retinoblastoma},
  journal = {Archives of Ophthalmology},
  year = {2012},
  volume = {130},
  number = {10},
  pages = {1268},
  doi = {10.1001/archophthalmol.2012.1983}
}
Kostenlos starten →